Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
965
-
Total 13F shares, excl. options
-
158M
-
Shares change
-
-1.51M
-
Total reported value, excl. options
-
$36.8B
-
Value change
-
-$346M
-
Put/Call ratio
-
1.19
-
Number of buys
-
369
-
Number of sells
-
-498
-
Price
-
$232.82
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q3 2019
1,122 filings reported holding BIIB - BIOGEN INC. - COM as of Q3 2019.
BIOGEN INC. - COM (BIIB) has 965 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 158M shares
.
Largest 10 shareholders include BlackRock Inc. (15.4M shares), PRIMECAP MANAGEMENT CO/CA/ (14.3M shares), VANGUARD GROUP INC (14.1M shares), STATE STREET CORP (8.44M shares), Clearbridge Investments, LLC (6.23M shares), RENAISSANCE TECHNOLOGIES LLC (4.22M shares), WELLINGTON MANAGEMENT GROUP LLP (3.67M shares), AQR CAPITAL MANAGEMENT LLC (3.52M shares), GEODE CAPITAL MANAGEMENT, LLC (3.34M shares), and Capital World Investors (3.25M shares).
This table shows the top 965 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.